NYSE : CRL

Charles River Laboratories International, Inc. — Financial statements

Healthcare · Diagnostics & Research · United States

Last price 359.41 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 17.16B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Charles River Laboratories International, Inc. (CRL) reported revenue of 4.00B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue4.00B4.02B4.05B4.13B3.98B3.54B
Cost of Revenue2.62B2.61B2.64B2.60B2.51B2.20B
Gross Profit1.38B1.40B1.41B1.53B1.47B1.34B
Selling, General & Admin728.96M727.81M723.62M742.85M655.58M578.23M
Amortization of Goodwill & Intangibles158.25M179.07M138.47M137.44M146.58M124.86M
Operating Expenses887.22M906.88M862.09M880.29M802.15M703.08M
Operating Income495.84M497.76M545.86M648.89M665.51M634.39M
Interest Expense-106.26M-107.03M-126.29M-136.71M-59.29M-73.91M
Interest & Investment Income4.50M4.94M8.57M5.20M780.00K652.00K
Earnings From Equity Investments-5.08M-24.91M-12.91M97.83M-26.77M-30.42M
Currency Exchange Gain (Loss)-46.53M-31.83M
Other Non Operating Income (Expenses)15.43M3.35M2.02M1.82M-18.40M7.79M
EBT Excluding Unusual Items404.43M374.11M417.26M617.03M515.29M506.67M
Merger & Restructuring Charges-105.11M-101.01M-108.48M-34.78M-15.71M-45.95M
Impairment of Goodwill-165.00M-165.00M-215.00M
Gain (Loss) on Sale of Assets-178.02M3.38M-659.00K-961.00K123.41M20.00M
Asset Writedown-139.97M-210.97M
Pretax Income-183.67M-99.50M93.11M581.28M622.99M480.71M
Income Tax Expense52.62M42.66M67.82M100.91M130.38M81.87M
Earnings From Continuing Operations-236.30M-142.16M25.29M480.37M492.61M398.84M
Net Income to Company-236.30M-142.16M25.29M480.37M492.61M398.84M
Minority Interest in Earnings-2.16M-2.17M-3.09M-5.75M-6.38M-7.86M
Net Income-238.46M-144.34M22.20M474.62M486.23M390.98M
Preferred Dividends & Other Adjustments11.91M
Net Income to Common-238.46M-144.34M10.30M474.62M486.23M390.98M
Shares Outstanding (Basic)48.85M49.56M51.38M51.23M50.81M50.29M
Shares Outstanding (Diluted)48.85M49.56M51.63M51.45M51.30M51.42M
EPS (Basic)-4.88-2.910.209.279.577.77
EPS (Diluted)-4.88-2.910.209.229.487.60
Free Cash Flow370.61M518.49M501.61M365.37M294.91M532.03M
Free Cash Flow Per Share7.5910.469.727.105.7510.35
Gross Margin34.59%34.98%34.76%37.03%36.91%37.78%
Operating Margin12.40%12.40%13.48%15.71%16.74%17.92%
Profit Margin-5.96%-3.60%0.25%11.49%12.23%11.04%
Free Cash Flow Margin9.27%12.91%12.38%8.85%7.42%15.03%
EBITDA849.12M876.57M870.50M963.01M969.38M899.93M
EBITDA Margin21.23%21.83%21.49%23.32%24.38%25.42%
D&A For EBITDA353.28M378.81M324.64M314.12M303.87M265.54M
EBIT495.84M497.76M545.86M648.89M665.51M634.39M
EBIT Margin12.40%12.40%13.48%15.71%16.74%17.92%
Effective Tax Rate72.84%17.36%20.93%17.03%
Revenue as Reported4.00B4.02B4.05B4.13B3.98B3.54B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents192.03M213.77M194.61M276.77M233.91M241.21M
Cash & Short-Term Investments192.03M213.77M194.61M276.77M233.91M241.21M
Receivables711.75M708.86M720.91M780.38M752.39M642.88M
Inventory346.26M299.10M278.54M380.26M255.81M199.15M
Prepaid Expenses100.41M96.11M103.21M87.88M89.34M93.54M
Restricted Cash24.43M666.00K9.54M5.80M6.19M4.02M
Other Current Assets154.23M128.55M96.26M77.58M101.39M93.29M
Total Current Assets1.53B1.45B1.40B1.61B1.44B1.27B
Property, Plant & Equipment1.83B2.02B2.02B2.03B1.86B1.58B
Long-Term Investments206.47M206.97M218.35M243.81M311.60M201.35M
Goodwill3.08B2.76B2.85B3.10B2.85B2.71B
Other Intangible Assets253.17M340.00M723.40M864.05M955.27M1.06B
Long-Term Deferred Tax Assets53.83M67.33M42.18M40.28M41.26M40.23M
Other Long-Term Assets587.56M293.19M278.23M309.38M148.28M151.54M
Total Assets7.53B7.14B7.53B8.20B7.60B7.02B
Accounts Payable140.98M148.80M140.34M168.94M205.91M198.13M
Accrued Expenses440.44M508.94M367.33M441.12M403.40M474.92M
Current Portion of Long-Term Debt5.46M166.00K155.00K3.17M1.35M101.00K
Current Portion of Leases1.17M60.89M56.93M57.31M48.86M35.96M
Current Income Taxes Payable45.03M39.00M31.90M38.80M39.90M26.20M
Current Unearned Revenue303.48M317.02M337.77M327.37M355.90M279.21M
Other Current Liabilities198.19M45.50M59.68M18.38M36.26M18.66M
Total Current Liabilities1.13B1.12B994.10M1.06B1.09B1.03B
Long-Term Debt2.61B2.11B2.21B2.62B2.68B2.64B
Long-Term Leases416.39M458.70M509.46M445.39M418.06M277.50M
Long-Term Unearned Revenue48.14M45.63M34.29M30.92M25.80M20.58M
Pension & Post-Retirement Benefits71.94M
Long-Term Deferred Tax Liabilities78.67M95.20M106.96M191.35M215.58M239.72M
Other Long-Term Liabilities282.43M92.67M160.92M192.27M147.50M222.28M
Total Liabilities4.64B3.92B4.02B4.54B4.58B4.43B
Common Stock496.00K492.00K511.00K513.00K509.00K505.00K
Additional Paid-In Capital1.99B1.95B1.97B1.91B1.80B1.72B
Retained Earnings1.37B1.39B1.81B1.89B1.43B980.75M
Treasury Stock-323.19M
Comprehensive Income & Other-195.99M-171.78M-317.35M-196.43M-262.06M-164.74M
Total Common Equity2.84B3.16B3.46B3.60B2.98B2.53B
Minority Interest48.89M46.56M46.58M62.12M47.21M57.17M
Shareholders' Equity2.89B3.21B3.51B3.66B3.02B2.59B
Total Liabilities & Equity7.53B7.14B7.53B8.20B7.60B7.02B
Total Debt3.03B2.63B2.78B3.13B3.15B2.95B
Net Cash (Debt)-2.84B-2.42B-2.59B-2.85B-2.92B-2.71B
Net Cash Per Share-58.18-48.78-50.10-55.39-56.82-52.73
Filing Date Shares Outstanding47.74M49.23M51.14M51.35M50.99M50.49M
Total Common Shares Outstanding47.73M49.22M51.14M51.34M50.94M50.48M
Working Capital394.36M326.73M408.97M553.58M347.45M240.91M
Book Value Per Share59.5064.3067.6970.0658.4250.21
Tangible Book Value-490.39M60.38M-108.50M-362.21M-828.88M-1.24B
Tangible Book Value Per Share-10.271.23-2.12-7.06-16.27-24.53
Land72.70M72.02M71.74M79.55M58.19M59.49M
Buildings1.10B1.10B1.07B1.05B963.72M987.54M
Machinery1.30B1.41B1.33B1.28B1.11B1.00B
Construction In Progress135.50M171.60M143.31M197.72M199.71M205.14M
Leasehold Improvements348.87M438.23M438.75M366.56M294.27M141.53M
Order Backlog2.66B2.79B

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-238.46M-144.34M22.20M474.62M486.23M390.98M
Depreciation & Amortization353.28M378.81M324.64M314.12M303.87M265.54M
Loss (Gain) From Sale of Assets142.90M-3.38M659.00K961.00K-123.41M-25.03M
Asset Writedown & Restructuring Costs348.16M424.08M276.23M41.91M5.82M733.00K
Loss (Gain) on Equity Investments5.08M24.91M12.91M-97.83M26.77M30.42M
Stock-Based Compensation83.06M71.08M69.89M72.05M73.62M71.47M
Provision & Write-off of Bad Debts5.00M6.06M14.77M18.23M6.71M1.66M
Other Operating Activities-12.24M-33.67M43.60M-37.79M-7.41M-17.92M
Change in Accounts Receivable-32.91M35.74M21.61M-33.43M-150.57M-26.63M
Change in Inventory8.92M-48.78M16.80M-62.30M-78.52M-25.16M
Change in Accounts Payable7.90M2.87M-14.27M-20.43M-2.65M44.90M
Change in Unearned Revenue-34.31M-23.49M25.12M-37.31M88.11M3.52M
Change in Other Net Operating Assets-54.24M47.74M-79.60M51.09M-8.92M46.31M
Operating Cash Flow582.15M737.65M734.58M683.90M619.64M760.80M
Capital Expenditures-211.54M-219.15M-232.97M-318.53M-324.73M-228.77M
Cash Acquisitions-467.25M-5.48M-194.78M-283.39M-1.29B
Divestitures176.56M17.44M163.28M122.69M
Investment in Securities-5.74M-10.97M-11.19M-47.55M-153.72M-39.02M
Other Investing Activities1.72M3.36M4.55M-2.29M-9.35M264.00K
Investing Cash Flow-506.25M-209.32M-245.09M-563.15M-607.92M-1.44B
Long-Term Debt Issued1.23B1.08B776.35M2.95B6.95B
Long-Term Debt Repaid-1.35B-1.49B-851.68M-2.93B-6.24B
Net Debt Issued (Repaid)321.89M-121.78M-412.19M-75.32M19.79M708.24M
Issuance of Common Stock2.33M714.00K23.88M25.60M25.11M45.65M
Repurchase of Common Stock-324.07M-360.67M-119.17M-24.16M-38.65M-40.71M
Other Financing Activities-21.57M-54.98M-43.44M-11.64M-48.65M-40.58M
Financing Cash Flow-21.42M-536.73M-550.93M-85.52M-42.40M672.60M
Foreign Exchange Rate Adjustments1.36M18.83M-17.47M8.04M25.58M17.73M
Net Cash Flow55.84M10.43M-78.91M43.27M-5.10M13.20M
Free Cash Flow370.61M518.49M501.61M365.37M294.91M532.03M
Free Cash Flow Margin9.27%12.91%12.38%8.85%7.42%15.03%
Free Cash Flow Per Share7.5910.469.727.105.7510.35
Levered Free Cash Flow468.86M572.38M489.63M214.21M303.66M629.60M
Unlevered Free Cash Flow535.27M639.28M568.56M299.65M340.72M675.80M
Cash Interest Paid99.80M101.72M123.45M132.10M100.75M70.78M
Cash Income Tax Paid63.43M119.64M126.10M90.40M75.91M75.44M
Change in Working Capital-104.63M14.08M-30.33M-102.38M-152.55M42.94M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization17.16B10.02B9.52B12.13B11.09B18.63B
Enterprise Value20.00B12.49B12.12B14.92B14.29B21.63B
Last Close Price359.41203.66186.16236.40217.90369.20
PE Ratio924.4925.5522.8047.65
Forward PE29.1519.3218.5322.7419.6633.72
PS Ratio4.292.502.352.942.795.26
PB Ratio6.043.122.713.313.677.19
P/TBV Ratio166.00
P/FCF Ratio46.3019.3318.9833.1937.5935.02
P/OCF Ratio29.4713.5912.9617.7317.8924.49
PEG Ratio2.501.822.521.861.652.15
EV/Sales Ratio5.003.112.993.613.596.11
EV/EBITDA Ratio23.5514.2513.9215.4914.7424.03
EV/EBIT Ratio40.3425.1022.2023.0021.4734.09
EV/FCF Ratio53.9724.0924.1640.8448.4540.65
Debt / Equity Ratio1.050.820.790.851.041.14
Debt / EBITDA Ratio3.152.672.862.973.023.11
Debt / FCF Ratio8.195.085.548.5610.685.55
Net Debt / Equity Ratio0.980.750.740.780.961.05
Net Debt / EBITDA Ratio3.352.762.972.963.013.01
Net Debt / FCF Ratio7.674.665.167.809.885.10
Asset Turnover0.530.550.520.520.540.57
Inventory Turnover8.369.048.028.1811.0311.45
Quick Ratio0.800.820.921.000.900.86
Current Ratio1.351.291.411.521.321.23
Return on Equity (ROE)-7.52%-4.23%0.71%14.38%17.54%16.84%
Return on Assets (ROA)4.11%4.24%4.34%5.13%5.69%6.34%
Return on Invested Capital (ROIC)8.55%8.49%2.35%8.62%9.36%11.22%
Return on Capital Employed (ROCE)7.80%8.30%8.40%9.10%10.20%10.60%
Earnings Yield-1.36%-1.44%0.23%3.91%4.39%2.10%
FCF Yield2.16%5.17%5.27%3.01%2.66%2.86%
Buyback Yield / Dilution3.44%4.00%-0.34%-0.29%0.24%-1.61%